|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0400 CAD | 0.00% |
|
+33.33% | -38.46% |
| Market Cap | 3.09M 2.18M 1.91M 1.76M 1.64M 206M 3.16M 21.18M 8.18M 102M 8.18M 8M 353M | P/E 2024 |
-9.02x | P/E 2025 | -2.81x |
|---|---|---|---|---|---|
| Enterprise Value | 3.27M 2.3M 2.01M 1.86M 1.74M 217M 3.34M 22.37M 8.64M 107M 8.64M 8.45M 372M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
84.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +33.33% | ||
| 3 months | +14.29% | ||
| 6 months | -38.46% | ||
| Current year | -38.46% |
| 1 week | 0.04 | 0.04 | |
| 1 month | 0.03 | 0.04 | |
| Current year | 0.03 | 0.1 | |
| 1 year | 0.02 | 0.14 | |
| 3 years | 0.02 | 0.2 | |
| 5 years | 0.02 | 0.95 | |
| 10 years | 0.02 | 4.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Roberto Fia
CEO | Chief Executive Officer | 55 | - |
Sung Min Myung
DFI | Director of Finance/CFO | 40 | 2019-10-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Roberto Fia
BRD | Director/Board Member | 55 | 2014-11-09 |
Andrew Peterson
CHM | Chairman | 78 | - |
Steve Naraine
BRD | Director/Board Member | - | 2023-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-14 | Sell | Chief Executive Officer | 2,000,000 | 4.3702% | ||
| 05-14 | Sell | Chief Executive Officer | 2,000,000 | 4.3702% | ||
| 03-03 | Tax | Chief Executive Officer | 187,500 | 0.4097% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +33.33% | -20.00% | -60.00% | 2.18M | ||
| +3.26% | -0.27% | -13.15% | -7.21% | 12.33B | ||
| +5.18% | 0.00% | -35.64% | -58.18% | 4.51B | ||
| +5.34% | +1.10% | -12.86% | -14.58% | 4.11B | ||
| +6.00% | +3.26% | +10.84% | -38.82% | 3.6B | ||
| +6.96% | +0.48% | +13.92% | -16.49% | 3.58B | ||
| +3.90% | +2.53% | -8.91% | -8.81% | 3.44B | ||
| +3.32% | -0.07% | -12.76% | -4.93% | 2.91B | ||
| +5.85% | +0.66% | -5.88% | -25.91% | 2.23B | ||
| +2.79% | -0.10% | -12.25% | +24.98% | 1.6B | ||
| Average | +4.26% | +3.39% | -9.67% | -21.00% | 3.83B | |
| Weighted average by Cap. | +4.50% | +0.14% | -10.12% | -17.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -388K -273K -239K -221K -206K -25.83M -397K -2.66M -1.03M -12.74M -1.03M -1M -44.24M | -1.06M -749K -656K -606K -565K -70.83M -1.09M -7.29M -2.81M -34.94M -2.81M -2.75M -121M |
| Net Debt | 68.01K 47.87K 41.91K 38.69K 36.13K 4.53M 69.56K 466K 180K 2.23M 180K 176K 7.75M | 174K 122K 107K 98.95K 92.4K 11.57M 178K 1.19M 460K 5.71M 460K 450K 19.82M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-29 | $0.0400 | 0.00% | 36,000 |
| 26-06-26 | $0.0400 | -11.11% | 69,000 |
| 26-06-25 | $0.0450 | +28.57% | 176,640 |
| 26-06-24 | $0.0350 | 0.00% | 15,000 |
| 26-06-23 | $0.0350 | +16.67% | 19,416 |
- Stock Market
- Stocks
- CVGR Stock
Select your edition
All financial news and data tailored to specific country editions
















